Intravenous beta-endorphin: behavioral and physiological effects in conscious monkeys

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Opioid peptides like beta-endorphin are endogenous analgesics.
• Morphine is a well-established exogenous opioid analgesic.
• Understanding the comparative effects of endogenous and exogenous opioids is crucial for pain management and addiction research.

Purpose of the Study:

• To compare the behavioral and physiological effects of systemically administered beta-endorphin and morphine in rhesus monkeys.
• To determine the relative potency of beta-endorphin and morphine in a non-human primate model.

Main Methods:

• Rhesus monkeys were trained on an operant schedule to assess behavioral responding.
• Intravenous administration of varying doses of beta-endorphin (0.7 and 2.8 mg/kg) and morphine (0.15 and 0.60 mg/kg).
• Monitoring of behavioral response rates, systolic blood pressure, and heart rate following drug administration.

Main Results:

• Beta-endorphin caused dose-dependent, brief disruptions in behavior, decreased systolic blood pressure, and increased heart rate.
• Morphine produced longer-lasting decreases in response rates and systolic blood pressure, with irregular heart rate changes.
• Beta-endorphin was found to be approximately twice as potent as morphine on a molar basis.

Conclusions:

• Intravenously administered beta-endorphin produces significant behavioral and physiological effects in unanesthetized rhesus monkeys.
• The findings suggest distinct pharmacokinetic or pharmacodynamic profiles between beta-endorphin and morphine in primates.
• Beta-endorphin's potency relative to morphine warrants further investigation into its therapeutic potential and mechanisms of action.